The Claim
Combining ezetimibe with statins results in a greater mean reduction in LDL cholesterol and reduced variability in individual LDL cholesterol response compared to statin monotherapy in adults with primary hypercholesterolemia.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with primary hypercholesterolemia, taking ezetimibe together with a statin leads to a larger average decrease in LDL cholesterol and more consistent results across individuals than taking a statin alone.
See the scientific wording
Combining ezetimibe with statins is associated with a greater mean LDL cholesterol reduction and less variability in response compared to statin monotherapy in adults with primary hypercholesterolemia.
Ezetimibe blocks cholesterol from entering the body through the gut, while statins stop the liver from making more cholesterol. Together, they reduce the total amount of cholesterol circulating in the blood more than either one alone, and everyone’s cholesterol drops more consistently because both pathways are targeted at the same time.
What the research says
1 studyWhen doctors add ezetimibe to a statin, patients’ bad cholesterol drops more on average, and everyone’s response becomes more similar — not as spread out as when using statins alone.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.